EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Arginine Methylation in Alternative Splicing: Implications for Cancer Therapy

Youyue Li, Shuyu Chen, Wenbo Ding, Bei Pan, Yujuan Yin, Xiaoqi Xin, Die Xia, Xueyang Wei, Siqi Bao, Mu Xu iD

Journal of Cellular Physiology · 2026-07 · 241 (7)

DOI: 10.1002/jcp.70206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 23.07.2026. Verfasst von Youyue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Alternative Splicing, Arginine, Neoplasms, Protein-Arginine N-Methyltransferases. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Nanjing Medical and Health Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arginine methylation is a common post‐translational modification that exists in three distinct forms—monomethylation, asymmetric dimethylation, and symmetric dimethylation—through which it regulates precursor RNA splicing and maintains cellular homeostasis. Dysregulation of the writing, reading, or erasure of arginine methylation promotes cancer development. Recent studies have identified PRMTs as key regulators of alternative splicing, and aberrant PRMT‐driven splicing directly impacts multiple biological processes, including tumor proliferation, apoptosis resistance, metastasis, and immune evasion. This review focuses on the molecular mechanisms by which PRMTs regulate alternative splicing, their connections to oncogenic processes, and the therapeutic implications and challenges of targeting the PRMT‐splicing axis in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingArginineNeoplasmsProtein-Arginine N-MethyltransferasesHumansMethylationAnimalsProtein Processing, Post-TranslationalGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

PRMTsalternative splicingarginine methylationcancer therapymethylarginines

Substanzen

ArginineProtein-Arginine N-Methyltransferases

Autor:innen und Institutionen

  • General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • School of Basic Medicine and Clinical Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

ORCID-Profile: Mu Xu

Förderung

  • National Natural Science Foundation of China
  • Nanjing Medical and Health Scientific Research Project

Zitieren

APA

Li, Y., Chen, S., Ding, W., Pan, B., Yin, Y., Xin, X., Xia, D., Wei, X., Bao, S., & Xu, M. (2026). Arginine Methylation in Alternative Splicing: Implications for Cancer Therapy. Journal of Cellular Physiology, 241(7). https://doi.org/10.1002/jcp.70206

Vancouver

Li Y, Chen S, Ding W, Pan B, Yin Y, Xin X, et al. Arginine Methylation in Alternative Splicing: Implications for Cancer Therapy. Journal of Cellular Physiology. 2026;241(7). doi:10.1002/jcp.70206

BibTeX
@article{Li2026,
  author = {Li, Youyue and Chen, Shuyu and Ding, Wenbo and Pan, Bei and Yin, Yujuan and Xin, Xiaoqi and Xia, Die and Wei, Xueyang and Bao, Siqi and Xu, Mu},
  title = {Arginine Methylation in Alternative Splicing: Implications for Cancer Therapy},
  journal = {Journal of Cellular Physiology},
  year = {2026},
  volume = {241},
  number = {7},
  doi = {10.1002/jcp.70206}
}
Kostenlos starten →